Security
Foghorn Therapeutics Inc. Common Stock · FHTX
FHTXNASDAQCommon stockCurrentCIK 1822462Updated Oct 6, 2026
FHTX price & chart
Loading TradingView…
NASDAQ:FHTX on TradingView ↗In the news
Next-Generation DNA Repair Therapies Open New Frontiers in Oncology ↗
Recent filings
3 filing
SCHEDULE 13G/A - filed by BIOTECHNOLOGY VALUE FUND L P regarding Foghorn Therapeutics Inc.
Costs Associated with Exit or Disposal Activities · Regulation FD Disclosure
Items 2.05, 7.01, 9.01
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 198,103,000Source | 283,982,000Source | 285,916,000Source | 404,883,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 80,876,000Source | 55,454,000Source | 80,336,000Source | 52,214,000Source |
| Assets, CurrentUSD | 163,235,000Source | 249,601,000Source | 240,181,000Source | 351,399,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 3,091,000Source | 5,854,000Source | 6,124,000Source | 5,601,000Source |
| Operating Lease, Right-of-Use AssetUSD | 30,949,000Source | 22,641,000Source | 29,956,000Source | 34,086,000Source |
| Other Assets, NoncurrentUSD | 4,000Source | 68,000Source | 1,115,000Source | 2,379,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 306,603,000Source | 329,510,000Source | 363,106,000Source | 404,771,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 6,000Source | 6,000Source | 4,000Source | 4,000Source |
| Additional Paid in CapitalUSD | 523,937,000Source | 512,515,000Source | 395,196,000Source | 377,232,000Source |
| Retained Earnings (Accumulated Deficit)USD | -632,467,000Source | -558,184,000Source | -471,564,000Source | -373,138,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 24,000Source | 135,000Source | -826,000Source | -3,986,000Source |
| Stockholders' Equity Attributable to ParentUSD | -108,500,000Source | -45,528,000Source | -77,190,000Source | 112,000Source |
| Liabilities and EquityUSD | 198,103,000Source | 283,982,000Source | 285,916,000Source | 404,883,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 59,738,000Source | 66,989,000Source | 58,436,000Source | 55,205,000Source |
| Operating Lease, Liability, CurrentUSD | 923,000Source | 9,067,000Source | 8,518,000Source | 5,970,000Source |
| Accounts Payable, CurrentUSD | 4,266,000Source | 3,785,000Source | 6,260,000Source | 5,414,000Source |
| Operating Lease, Liability, NoncurrentUSD | 40,347,000Source | 28,064,000Source | 36,555,000Source | 45,537,000Source |
| Other Liabilities, NoncurrentUSD | 556,000Source | — | 0Source | 29,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 11,357,000Source | 8,531,000Source | 9,108,000Source | 11,001,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 3,332,000Source | 3,120,000Source | 3,451,000Source | 3,321,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 10,399,000Source | 11,893,000Source | 16,186,000Source | 14,336,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | 481,000Source | -2,475,000Source | 846,000Source | 1,614,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -86,099,000Source | -100,406,000Source | -118,106,000Source | 193,612,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 112,040,000Source | -29,904,000Source | 144,450,000Source | -244,322,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 50,000Source | 906,000Source | 1,224,000Source | 1,210,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 1,023,000Source | 105,428,000Source | 1,778,000Source | 1,763,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 84,126,000Source | 57,162,000Source | 82,044,000Source | 53,922,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | 3,551,000Source | 0Source |
| Income Taxes Paid, NetUSD | 9,000Source | 860,000Source | — | — |
| Additional Financial Items | ||||
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | -31,000Source | 0Source | -3,000Source | -6,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | 0Source |
| General and Administrative ExpenseUSD | 27,550,000Source | 28,359,000Source | 32,372,000Source | 30,747,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 4,226,000Source | — |
| Marketable Securities, Unrealized Gain (Loss)USD | -111,000Source | 961,000Source | 3,160,000Source | -3,976,000Source |
| Net Income (Loss) Attributable to ParentUSD | -74,283,000Source | -86,620,000Source | -98,426,000Source | -108,882,000Source |
| Nonoperating Income (Expense)USD | 12,106,000Source | 16,063,000Source | 13,706,000Source | 8,255,000Source |
| Operating ExpensesUSD | 117,298,000Source | 125,285,000Source | 142,061,000Source | 136,365,000Source |
| Other Nonoperating Income (Expense)USD | — | — | — | 2,580,000Source |
| Proceeds from Issuance of Common StockUSD | — | 103,401,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | 483,000Source | 2,612,000Source | 1,778,000Source | 1,763,000Source |
| Stock or Unit Option Plan ExpenseUSD | — | — | — | 14,336,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 30,909,000Source | 22,602,000Source | 34,155,000Source | 19,228,000Source |
| Operating Income (Loss)USD | -86,389,000Source | -102,683,000Source | -107,906,000Source | -117,137,000Source |
| Other Nonoperating Income (Expense)USD | — | — | — | 2,580,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | -86,620,000Source | -94,200,000Source | — |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 4,226,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | -74,283,000Source | -86,620,000Source | -98,426,000Source | -108,882,000Source |
| Earnings Per Share, BasicUSD per share | -1.18Source | -1.58Source | -2.34Source | -2.62Source |
| Earnings Per Share, DilutedUSD per share | -1.18Source | -1.58Source | -2.34Source | -2.62Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 62,980,959Source | 54,899,432Source | 41,974,484Source | 41,591,433Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 62,980,959Source | 54,899,432Source | 41,974,484Source | 41,591,433Source |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | 27,550,000Source | 28,359,000Source | 32,372,000Source | 30,747,000Source |
| Interest Income, OtherUSD | 8,745,000Source | 11,900,000Source | 10,875,000Source | 5,675,000Source |
| Nonoperating Income (Expense)USD | 12,106,000Source | 16,063,000Source | 13,706,000Source | 8,255,000Source |
| Operating ExpensesUSD | 117,298,000Source | 125,285,000Source | 142,061,000Source | 136,365,000Source |
| Research and Development ExpenseUSD | 85,466,000Source | 94,528,000Source | 109,689,000Source | 105,618,000Source |